EN ISO 17665:2024

SLOVENSKI STANDARD
01-julij-2024
Sterilizacija izdelkov za zdravstveno nego - Vlažna toplota - Zahteve za razvoj,
validacijo in rutinsko kontrolo sterilizacijskih postopkov za medicinske
pripomočke (ISO 17665:2024)
Sterilization of health care products - Moist heat - Requirements for the development,
validation and routine control of a sterilization process for medical devices (ISO
17665:2024)
Sterilisation von Produkten für die Gesundheitsfürsorge - Feuchte Hitze - Anforderungen
an die Entwicklung, Validierung und Lenkung der Anwendung eines
Sterilisationsverfahrens für Medizinprodukte (ISO 17665:2024)
Stérilisation des produits de santé - Chaleur humide - Exigences pour le développement,
la validation et le contrôle de routine d’un procédé de stérilisation des dispositifs
médicaux (ISO 17665:2024)
Ta slovenski standard je istoveten z: EN ISO 17665:2024
ICS:
11.080.01 Sterilizacija in dezinfekcija na Sterilization and disinfection
splošno in general
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

EN ISO 17665
EUROPEAN STANDARD
NORME EUROPÉENNE
May 2024
EUROPÄISCHE NORM
ICS 11.080.01 Supersedes EN ISO 17665-1:2006, CEN ISO/TS 17665-
2:2009
English Version
Sterilization of health care products - Moist heat -
Requirements for the development, validation and routine
control of a sterilization process for medical devices (ISO
17665:2024)
Stérilisation des produits de santé - Chaleur humide - Sterilisation von Produkten für die
Exigences pour le développement, la validation et le Gesundheitsfürsorge - Feuchte Hitze - Anforderungen
contrôle de routine d'un procédé de stérilisation des an die Entwicklung, Validierung und Lenkung der
dispositifs médicaux (ISO 17665:2024) Anwendung eines Sterilisationsverfahrens für
Medizinprodukte (ISO 17665:2024)
This European Standard was approved by CEN on 3 December 2023.

CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this
European Standard the status of a national standard without any alteration. Up-to-date lists and bibliographical references
concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN
member.
This European Standard exists in three official versions (English, French, German). A version in any other language made by
translation under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management
Centre has the same status as the official versions.

CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Republic of North Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Türkiye and
United Kingdom.
EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION

EUROPÄISCHES KOMITEE FÜR NORMUNG

CEN-CENELEC Management Centre: Rue de la Science 23, B-1040 Brussels
© 2024 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 17665:2024 E
worldwide for CEN national Members.

Contents Page
European foreword . 3
Annex ZA (informative) Relationship between this European standard and the General
Safety and Performance Requirements of Regulation (EU) 2017/745 aimed to be
covered. 4
Annex ZB (informative) Relationship between this European standard and the General
Safety and Performance Requirements of Regulation (EU) 2017/746 aimed to be
covered. 9

European foreword
This document (EN ISO 17665:2024) has been prepared by Technical Committee ISO/TC 198
"Sterilization of health care products" in collaboration with Technical Committee CEN/TC 204
“Sterilization of medical devices” the secretariat of which is held by BSI.
This European Standard shall be given the status of a national standard, either by publication of an
identical text or by endorsement, at the latest by November 2024, and conflicting national standards
shall be withdrawn at the latest by November 2024.
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. CEN shall not be held responsible for identifying any or all such patent rights.
This document supersedes EN ISO 17665-1:2006 and CEN ISO/TS 17665-2:2009.
This document has been prepared under a standardization request addressed to CEN by the European
Commission. The Standing Committee of the EFTA States subsequently approves these requests for its
Member States.
For the relationship with EU Legislation, see informative Annex ZA or ZB, which is an integral part of
this document.
Any feedback and questions on this document should be directed to the users’ national standards
body/national committee. A complete listing of these bodies can be found on the CEN website.
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the
following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria,
Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of
North Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Türkiye and the
United Kingdom.
Endorsement notice
The text of ISO 17665:2024 has been approved by CEN as EN ISO 17665:2024 without any modification.

Annex ZA
(informative)
Relationship between this European standard and the General Safety and
Performance Requirements of Regulation (EU) 2017/745 aimed to be
covered
This European standard has been prepared under M/575 to provide one voluntary means of
conforming to the General Safety and Performance Requirements of Regulation (EU) 2017/745 of 5
April 2017 concerning medical devices [OJ L 117] and to system or process requirements including
those relating to quality management systems, risk management, post-market surveillance systems,
clinical investigations, clinical evaluation or post-market clinical follow-up.
Once this standard is cited in the Official Journal of the European Union under that Regulation,
compliance with the normative clauses of this standard given in Table ZA.1 and application of the
edition of the normatively referenced standards as given in Table ZA.2 confers, within the limits of the
scope of this standard, a presumption of conformity with the corresponding General Safety and
Performance Requirements of that Regulation, and associated EFTA Regulations.
Where a definition in this standard differs from a definition of the same term set out in Regulation (EU)
2017/745, the differences shall be indicated in this Annex Z. For the purpose of using this standard in
support of the requirements set out in Regulation (EU) 2017/745, the definitions set out in this
Regulation prevail. In this context, the definition of ‘medical device’ in this standard is a modified
version of the definition prepared by the Global Harmonization Task Force with modification to the
Note in the definition.
Where the European standard is an adoption of an International Standard, the scope of this standard
can differ from the scope of the European Regulation that it supports. As the scope of the applicable
regulatory requirements differ from nation to nation and region to region, the standard can only
support European regulatory requirements to the extent of the scope of the European regulation for
medical devices (EU) 2017/745).
NOTE 1 Where a reference from a clause of this standard to the risk management process is made, the risk
management process needs to be in compliance with Regulation (EU) 2017/745. This means that risks have to be
‘reduced as far as possible’, ‘reduced to the lowest possible level’, ‘reduced as far as possible and appropriate’,
‘removed or reduced as far as possible’, ‘eliminated or reduced as far as possible’, ’removed or minimized as far as
possible’, or ‘minimized’, according to the wording of the corresponding General Safety and Performance
Requirement.
NOTE 2 The manufacturer’s policy for determining acceptable risk must be in compliance with General Safety
and Performance Requirements 1, 2, 3, 4, 5, 8, 9, 10, 11, 14, 16, 17, 18, 19, 20, 21 and 22 of the Regulation.
NOTE 3 When a General Safety and Performance Requirement does not appear in Table ZA.1, it means that it is
not addressed by this European Standard.
Table ZA.1 — – Correspondence between this European standard and Annex I of Regulation (EU)
2017/745 [OJ L 117] and to system or process requirements including those relating to quality
management systems, risk management, post-market surveillance systems, clinical
investigations, clinical evaluation or post-market clinical follow-up
General Safety and
Clause(s) / sub-
Performance
clause(s)
Remarks / Notes
Requirements of
of this EN
Regulation (EU) 2017/745
11.3 4,5,6,7,8,9,10,11,12 This standard provides requirements for
the development, validation and routine
control of a sterilization process using
moist heat for medical devices, including
requirements that the medical device is
safe and performs as intended after
treatment. It could also be applied to the
development, validation and routine
control of a process for attainment of a
specific microbial state other than sterility.
This General Safety and Performance
Requirement is addressed only with regard
to devices for which treatment by moist
heat is appropriate.
This relevant General Safety and
Performance Requirement is only partly
addressed in this European Standard.
Design and packaging for maintenance of a
specific microbial state during
transportation and storage are not covered.
Aspects of manufacture other than those
related to attainment of a specific microbial
state using moist heat are not covered.
11.4 first sentence only 4,5,6,7,8,9,10,11,12 This standard provides requirements for
the development, validation and routine
control of a sterilization process using
moist heat for medical devices, including
requirements that the sterilized medical
device is safe and performs as intended
after sterilization. This General Safety and
Performance Requirement is addressed
only with regard to devices for which
sterilization by moist heat is appropriate.
This relevant General Safety and
Performance Requirement is only partly
addressed in this European Standard.
Design and packaging for maintenance of
sterility during transportation and storage
are not covered. Aspects of manufacture
other than those related to attainment of
sterility by moist heat are not covered.
Evidence that the integrity of the packaging
General Safety and
Clause(s) / sub-
Performance
clause(s)
Remarks / Notes
Requirements of
of this EN
Regulation (EU) 2017/745
is maintained to the point of use is not
covered.
11.5 4,5,6,7,8,9,10,11,12 This standard provides requirements for
the development, validation and routine
control of a sterilization process using
moist heat for medical devices, including
requirements that the sterilized medical
device is safe and performs as intended
after sterilization. This General Safety and
Performance Requirement is addressed
only with regard to devices for which
sterilization by moist heat is appropriate.
This relevant General Safety and
Performance Requirement is only partly
addressed in this European Standard.
Packaging for maintenance of sterility is
not covered. Aspects of manufacture other
than those related to attainment of sterility
using moist heat are not covered.
Table ZA.2 — Applicable Standards to confer presumption of conformity as described in this
Annex ZA
Column 1 Column 2 Column 3 Column 4
Reference in International Title Corresponding European
Clause 2 Standard Edition Standard Edition
ISO 11140-1 ISO 11140-1:2014 Sterilization of health care EN ISO 11140-1:2014
products — Chemical
indicators — Part 1:
General requirements
ISO 11140-3 ISO 11140-3:2007 Sterilization of health care EN ISO 11140-3:2009
products — Chemical
indicators — Part 3: Class 2
indicator systems for use in
the Bowie and Dick-type
steam penetration test
ISO 11140-4 ISO 11140-4:2007 Sterilization of health care EN ISO 11140-4:2007
products — Chemical
indicators — Part 4: Class 2
indicators as an alternative
to the Bowie and Dick-type
test for detection of steam
penetration
ISO 11140-5 ISO 11140-5:2007 Sterilization of health care None
products — Chemical
For applicable standard edition
indicators — Part 5: Class 2
see Column 2
indicators for Bowie and
Dick-type air removal tests
ISO 11140-6 ISO 11140-6:2022 Sterilization of health care EN ISO 11140-6:2022
products — Chemical
indicators — Part 6: Type 2
indicators and process
challenge devices for use in
performance testing of
small steam sterilizers.
ISO 11607-1 ISO 11607-1:2019 Packaging for terminally EN ISO 11607-
sterilized medical devices 1:2020+A11:2022
— Part 1: Requirements for
materials, sterile barrier
systems and packaging
systems
ISO 11607-2 ISO 11607-2:2019 Packaging for terminally EN ISO 11607-
sterilized medical devices 2:2020+A11:2022
— Part 2: Validation
requirements for forming,
sealing and assembly
processes
ISO 11737-1 ISO 11737- Sterilization of health care EN ISO 11737-1:2018+A1:2021
----------------------
...